← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 31, 2022Last known activity
Jun 13, 2023
Timeline
2010s
- Jan 1, 2018
Neurogene Inc.— Founded
2020s
- Jul 18, 2023
Neoleukin— Acquired
Drugs by trial phase (3 distinct, 3 trials)
Phase 1 (0 own, 1 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (4)
- NCT05898620Lead sponsorPhase 1/Phase 2Jun 13, 2023
- NCT05898620Study directorPhase 1/Phase 2Jun 13, 2023
- NCT05228145Lead sponsorPhase 1/Phase 2Jan 31, 2022
- NCT05228145Study directorPhase 1/Phase 2Jan 31, 2022
Details
- Founded
- New York, NY, US Jan 1, 2018
- Last known activity
- Jun 13, 2023